Life-safety calibrated
Engagements designed around clinical operational continuity. We don't disrupt to defend — we preempt so disruption never happens.
Hospital networks. Pharmaceutical majors. Biotech and gene-therapy research. Medical device manufacturers. The sector where ransomware no longer attacks data — it attacks patients. Where IP theft is state-sponsored. Where supply-chain compromise reaches into surgical theatres.
Healthcare faces a structurally different threat surface from most enterprise sectors. Patient lives are directly exposed. Research IP is targeted by state actors with multi-decade horizons. Supply chains cross dozens of jurisdictions. Regulatory complexity creates security gaps rather than closing them. Fiive Eyes operates as the layer that engages where conventional healthcare security stops — pre-emptively against named threat actors, with response capability calibrated to clinical reality.
Each sector faces a different operating reality. Fiive Eyes is calibrated — not customized — to the structural specifics of how you operate, what's at stake, and what success looks like.
Engagements designed around clinical operational continuity. We don't disrupt to defend — we preempt so disruption never happens.
IFC0 monitoring tuned to nation-state IP-theft operations targeting biotech, gene therapy, vaccine research, and medical device innovation.
HUNT engagement against ransomware operations before they reach clinical infrastructure. Detection at staging, neutralization at infrastructure, not at impact.
C-suite and high-value patient protection for sovereign-tier clientele, ruling-family medical needs, geopolitically exposed individuals.
Not every engagement requires every zone. The architecture exists so capability matches need — precisely, proportionately, sovereignly.
Four phases. Discreet at every stage. Bespoke to your operational reality.
Threat assessment calibrated to your clinical, research, or commercial profile. Tone matches sector.
Engagement focused on specific threat geometries — ransomware, IP theft, supply-chain risk, principal protection.
Deployment alongside existing healthcare security operations with minimal clinical disruption.
24/7 monitoring with escalation protocols calibrated to clinical reality; quarterly executive review.